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Introduction {#rcr2426-sec-0001}
============

Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) has been widely used and is currently the standard method for the assessment of mediastinal and hilar lymphadenopathy [1](#rcr2426-bib-0001){ref-type="ref"}. This procedure can be performed for multiple mediastinal and hilar lymph nodes under moderate sedation, even on an outpatient basis [2](#rcr2426-bib-0002){ref-type="ref"}. Although EBUS‐TBNA has been reported to be a minimally invasive and relatively safe procedure, complications have been gradually reported [3](#rcr2426-bib-0003){ref-type="ref"}. Some of these complications can be serious, with mediastinitis presenting as an important acute or sub‐acute complication requiring precise diagnosis and treatment [4](#rcr2426-bib-0004){ref-type="ref"}, [5](#rcr2426-bib-0005){ref-type="ref"}, [6](#rcr2426-bib-0006){ref-type="ref"}. The median time of mediastinitis onset after EBUS‐TBNA, estimated by these previous reports, was 12.5 days (interquartile range: 2.75--14.5 days) [4](#rcr2426-bib-0004){ref-type="ref"}, [7](#rcr2426-bib-0007){ref-type="ref"}, [8](#rcr2426-bib-0008){ref-type="ref"}, [9](#rcr2426-bib-0009){ref-type="ref"}, [10](#rcr2426-bib-0010){ref-type="ref"}, [11](#rcr2426-bib-0011){ref-type="ref"}, [12](#rcr2426-bib-0012){ref-type="ref"}, [13](#rcr2426-bib-0013){ref-type="ref"}. Here we describe two rare cases in which severe mediastinitis occurred over a month after EBUS‐TBNA.

Case Reports {#rcr2426-sec-0002}
============

Case 1 {#rcr2426-sec-0003}
------

A 67‐year‐old woman with an unremarkable medical history was referred to our hospital for evaluation of a cystic mass with a 55 mm diameter in the middle mediastinum (Fig. [1](#rcr2426-fig-0001){ref-type="fig"}A). EBUS‐TBNA was performed for diagnosis, and histopathological analysis revealed only mucoid substances without malignancy or bacteria; therefore, no treatment was administered. The patient returned 48 days later with complaints of right‐sided back pain and dysphasia for a week. On admission, she exhibited general malaise, an increased body temperature of 37.5°C, and an oxygen saturation of 97% on room air. Physical examination demonstrated no lymphadenopathy or cardiopulmonary abnormalities. Laboratory examinations revealed an increased white blood cell (WBC) count (10,500/mm^3^) and C‐reactive protein (CRP) level (8.9 mg/dL). A chest radiograph showed increased mediastinal widening, and chest computed tomography (CT) demonstrated enlargement of the mediastinal mass that compressed the airway (Fig. [1](#rcr2426-fig-0001){ref-type="fig"}B). Intravenous antibiotic treatment (flomoxef, 2 g/day) was initiated; however, her abnormal laboratory test findings deteriorated. Three days after admission, she underwent right posterolateral thoracotomy for both drainage and release of the airway compression. A cloudy yellow fluid containing *Eikenella corrodens*, which is normal oral flora, was obtained via drainage. The organism was sensitive to ampicillin, ampicillin/sulbactam, cefotiam, meropenem, levofloxacin, and trimethoprim/sulfamethoxazole, but resistant to tetracycline. The patient recovered and was discharged after two weeks of post‐operative antibiotic therapy (tazobactam/piperacillin, 13.5 g/day).

![Chest computed tomography (CT) in case 1 (A, B) and in case 2 (C, D) before (A, C) and after (B, D) endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA), respectively.](RCR2-7-e00426-g001){#rcr2426-fig-0001}

Case 2 {#rcr2426-sec-0004}
------

A 47‐year‐old man presented at our hospital for further examination of bilateral hilar and mediastinal lymphadenopathy (Fig. [1](#rcr2426-fig-0001){ref-type="fig"}C). He underwent EBUS‐TBNA for the subcarinal lymph nodes (\#7), and histopathological analysis showed epithelioid granulomas without caseous necrosis, which was consistent with a diagnosis of sarcoidosis. The patient developed high fever, chest pain, and headache 53 days after EBUS‐TBNA. Oral antibiotic therapy (levofloxacin, 500 mg/day) was prescribed by a general physician, but his symptoms persisted, and he was readmitted to our hospital. On examination, he exhibited general malaise, an increased body temperature of 37.1°C, and an oxygen saturation of 98% on room air. Pulmonary and cardiovascular physical examinations showed normal findings. Laboratory tests showed an increased WBC count (21,200/mm^3^) and CRP level (11.9 mg/dL), and chest CT showed enlargement of the subcarinal lymph node with a low‐density area (Fig. [1](#rcr2426-fig-0001){ref-type="fig"}D). Intravenous antibiotic therapy (tazobactam/piperacillin, 18 g/day) was initiated and surgical drainage was performed on day 2 of hospitalization. The abscess was drained via right mediastinotomy, and the drained fluid exhibited white purulent material. No bacteria were detected. His post‐operative course was uneventful, and he was discharged 14 days after hospitalization.

Discussion {#rcr2426-sec-0005}
==========

In this report, we have described, to the best of our knowledge, the first two cases of mediastinitis that occurred over a month after EBUS‐TBNA. The two cases reported here convey two important messages. First, mediastinitis can occur over a month after EBUS‐TBNA. Second, *E. corrodens* must be considered as one of the pathogenic bacteria that can cause this complication.

EBUS‐TBNA is becoming increasingly popular and has almost replaced mediastinoscopy as a diagnostic and staging modality for both benign and malignant mediastinal and lung masses or adenopathy [14](#rcr2426-bib-0014){ref-type="ref"}. This is because its diagnostic sensitivity ranges from 85% to 100%, similar to that of mediastinoscopy [15](#rcr2426-bib-0015){ref-type="ref"}. Moreover, the complication rate for EBUS‐TBNA is 1.02%, which is considerably lower than that for mediastinoscopy (2%--3%) [3](#rcr2426-bib-0003){ref-type="ref"}, [16](#rcr2426-bib-0016){ref-type="ref"}. Common complications of EBUS‐TBNA include infection, haemorrhage, pneumothorax, and respiratory failure [3](#rcr2426-bib-0003){ref-type="ref"}. In Japan, the reported incidence of infectious complications after EBUS‐TBNA was 0.19%, with mediastinitis accounting for 0.10% cases [17](#rcr2426-bib-0017){ref-type="ref"}. Mediastinitis is a rare but important complication because it can occur as a progressive and occasionally life‐threatening condition requiring surgical intervention [4](#rcr2426-bib-0004){ref-type="ref"}, [5](#rcr2426-bib-0005){ref-type="ref"}.

We searched the PubMed database for reported cases of mediastinitis after EBUS‐TBNA and retrieved a total of 13 cases [4](#rcr2426-bib-0004){ref-type="ref"}, [7](#rcr2426-bib-0007){ref-type="ref"}, [8](#rcr2426-bib-0008){ref-type="ref"}, [9](#rcr2426-bib-0009){ref-type="ref"}, [10](#rcr2426-bib-0010){ref-type="ref"}, [11](#rcr2426-bib-0011){ref-type="ref"}, [12](#rcr2426-bib-0012){ref-type="ref"}, [13](#rcr2426-bib-0013){ref-type="ref"}. In addition to the two cases reported here, the patient characteristics, clinical courses, pathogens, and treatments for these 13 cases and a case treated at our hospital are shown in Table [1](#rcr2426-tbl-0001){ref-type="table"} (*n* = 16). The median time of mediastinitis onset after EBUS‐TBNA, estimated by these previous reports, was 12.5 days (interquartile range: 2.75--14.5 days) [4](#rcr2426-bib-0004){ref-type="ref"}, [7](#rcr2426-bib-0007){ref-type="ref"}, [8](#rcr2426-bib-0008){ref-type="ref"}, [9](#rcr2426-bib-0009){ref-type="ref"}, [10](#rcr2426-bib-0010){ref-type="ref"}, [11](#rcr2426-bib-0011){ref-type="ref"}, [12](#rcr2426-bib-0012){ref-type="ref"}, [13](#rcr2426-bib-0013){ref-type="ref"}. The most common pathogens were *Streptococcus* spp. (four of nine cases), which are considered normal oral flora, suggesting that infection is caused via the contaminated needle of TBNA. Surgical intervention was required for 10 of 16 cases in whom systemic antibiotic therapy proved inadequate.

###### 

Patients characteristics, clinical course, pathogens, and treatments for previous cases of mediastinitis after EBUS‐TBNA.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Age/sex   Antibiotic treatment before/after EBUS‐TBNA   Final diagnosis by EBUS‐TBNA           Number of days after EBUS‐TBNA   Treatment            Pathogen                                   Reference
  --------- --------------------------------------------- -------------------------------------- -------------------------------- -------------------- ------------------------------------------ -----------------------------------------
  72/M      None                                          Necrotic tissue                        2 days                           Surgery              Group C *Streptococcus*                    [7](#rcr2426-bib-0007){ref-type="ref"}

  68/M      None                                          Lung cancer (SCLC)                     2 days                           Antibiotic therapy   NR                                         [8](#rcr2426-bib-0008){ref-type="ref"}

  58/F      None                                          Lung cancer (SQ)                       2 days                           Antibiotic therapy   NR                                         [9](#rcr2426-bib-0009){ref-type="ref"}

  33/F      None                                          Cyst                                   3 days                           Surgery              *Staphylococcus epdermidis*                [10](#rcr2426-bib-0010){ref-type="ref"}

  51/M      None                                          Pneumoconiosis                         3 days                           Antibiotic therapy   *Gamella morbillorum*                      [11](#rcr2426-bib-0011){ref-type="ref"}

  51/M      None                                          Pneumoconiosis                         3 days                           Antibiotic therapy   *Gamella morbillorum*                      [11](#rcr2426-bib-0011){ref-type="ref"}

  73/M      None                                          Lung cancer (SQ)                       11 days                          Antibiotic therapy   NR                                         [12](#rcr2426-bib-0012){ref-type="ref"}

  70/F      None                                          Lung cancer (ADC)                      14 days                          Surgery              *Strepctococcus intermedius*               Our hospital case

  64/M      None                                          Metastatic lung cancer(colon cancer)   14 days                          Surgery              NR                                         [13](#rcr2426-bib-0013){ref-type="ref"}

  49/M      None                                          Granuloma                              14 days                          Surgery              *Gemella mobillorum*                       [13](#rcr2426-bib-0013){ref-type="ref"}

  36/M      None                                          Sarcoidosis                            16 days                          Surgery              *Prevotella buccae*,\                      [13](#rcr2426-bib-0013){ref-type="ref"}
                                                                                                                                                       *Streptococcus anginosus*, *Actinomyces*   

  50/M      None                                          Lung cancer (ADC)                      19 days                          Surgery              *Actinomyces odontolyticus*,\              [9](#rcr2426-bib-0009){ref-type="ref"}
                                                                                                                                                       *Streptococcus mutans*                     

  48/M      None                                          NR                                     21 days                          Surgery              *Klebsiella pneumoniae*                    [4](#rcr2426-bib-0004){ref-type="ref"}

  67/F      None                                          Bronchogenic cyst                      40 days                          Surgery              *Eikenella corrodens*                      Case 1

  47/M      None                                          Sarcoidosis                            53 days                          Surgery              None                                       Case 2

  59/M      NR                                            NR                                     NR                               Antibiotic therapy   NR                                         [18](#rcr2426-bib-0018){ref-type="ref"}

  67/M      NR                                            NR                                     NR                               Antibiotic therapy   NR                                         [18](#rcr2426-bib-0018){ref-type="ref"}
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: ADC, adenocarcinoma; CLDM, clindamycin; EBUS‐TBNA, endobronchial ultrasound‐guided transbronchial needle aspiration; NR, not reported; SCLC, small cell lung carcinoma; SQ, squamous cell carcinoma.

In the present cases, mediastinitis developed 40 and 53 days after EBUS‐TBNA. This indicates that mediastinitis must be considered even if patients present with symptoms over a month after EBUS‐TBNA. Although the precise reason for the late onset is unclear, one hypothesis is that the inflammation in the patients was restricted (e.g. cyst); hence, a systemic inflammatory response was not evoked. Another hypothesis is that the condition was caused by a low‐virulence pathogen, which resulted in slow disease development. In particular, *E. corrodens* detected in case 1, which can lead to pneumonia or empyema even in immunocompetent patients, is a slow‐growing microorganism that appears to be indolent [19](#rcr2426-bib-0019){ref-type="ref"}. Although the characteristics of the pathogen may be related to the time of onset of mediastinitis, further investigation is necessary to confirm such an association.

Currently, there is no consensus regarding prophylactic measures for infectious complications after EBUS‐TBNA. Randomized studies have revealed that the use of prophylactic antibiotics after conventional diagnostic bronchoscopy did not alter the frequency of infectious events [20](#rcr2426-bib-0020){ref-type="ref"}, [21](#rcr2426-bib-0021){ref-type="ref"}. Therefore, the British Thoracic Society Guidelines for diagnostic and therapeutic bronchoscopy does not recommend antibiotic prophylaxis for the prevention of infection. While we have previously reported that antibiotic prophylaxis was unrelated to the development of fever after the procedure even in EBUS‐TBNA [22](#rcr2426-bib-0022){ref-type="ref"}, the preventive effects of prophylactic antibiotics against the infectious complications like a mediastinitis associated with EBUS‐TBNA remain uncertain. Some possible factors associated with the development of mediastinitis after EBUS‐TBNA have been reported as follows: number of times the needle is passed into the lesion, number of samples obtained per lesion, operator expertise, presence of necrotic or cystic lesions, and bacterial contamination of the working channel [13](#rcr2426-bib-0013){ref-type="ref"}. Although there is no strong evidence supporting these factors, there are some reports of mediastinitis after EBUS‐TBNA of cystic lesions [7](#rcr2426-bib-0007){ref-type="ref"}, [10](#rcr2426-bib-0010){ref-type="ref"}. Considering case 1 and other reports, we no longer perform EBUS‐TBNA for cystic lesions. Additionally, to identify whether the lesion is cystic, magnetic resonance imaging or contrast enhanced CT may be considered prior to the examination. Additional investigation to detect the risk factors involving procedures and comorbidity may contribute to prevention of infectious complications after EBUS‐TBNA.

In conclusion, we described two cases of severe mediastinitis with delayed onset after EBUS‐TBNA that were successfully treated using a surgical approach. The findings from these cases suggest that early diagnosis is essential for appropriate treatment. Clinicians should consider mediastinitis even if symptoms appear over a month after EBUS‐TBNA. Moreover, identification of the pathogenic organism is important for appropriate treatment.
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